| Paquinimod |
帕奎莫德 |
248282-01-1 |
| CIVENTICHEM CV-4057 |
拉喹莫德 |
248281-84-7 |
| MRS 1706 |
MRS 1706 |
264622-53-9 |
| ADH 1 |
N-钙粘蛋白拮抗剂 |
229971-81-7 |
| Atazanavir sulfate |
阿扎那韦硫酸盐 |
229975-97-7 |
| Cyclic Arg-Gly-Asp-D-Tyr-Lys |
环(RGDYK)二三氟醋酸盐 |
250612-42-1 |
| Urea, N-[5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)Methyl]-2-Methyl-1-piperazinyl]-2-oxoethoxy]phenyl]- |
(R)-1-(5-氯-2-(2-(4-(4-氟苄基)-2-甲基哌嗪-1-基)-2-氧代乙氧基)苯基)脲 |
217645-70-0 |
| NU 6027 |
NU6027 |
220036-08-8 |
| PD184352 |
2-[(2-氯-4-碘苯基)氨基]-N-(环丙基甲氧基)-3,4-二氟-苯甲酰胺 |
212631-79-3 |
| FARAMPATOR |
CX691 |
211735-76-1 |
| PD 173074 |
PD173074 |
219580-11-7 |
| SRPK inhibitor |
SRPKINHIBITOR |
218156-96-8 |
| Entinostat |
恩替诺特 |
209783-80-2 |
| γ-Secretase Inhibitor XXI |
N-[(1S)-2-[[(3S)-2,3-二氢-1-甲基-2-氧代-5-苯基-1H-1,4-苯并二氮杂卓-3-基]氨基]-1-甲基-2-氧代乙基]-3,5-二氟苯乙酰胺 |
209986-17-4 |
| Sitaxentan sodium |
西他生坦钠 |
210421-74-2 |
| WBYNZQXAAWPAGR-UHFFFAOYSA-N |
CS-2866 |
1637300-25-4 |
| IDH-305 |
IDH305 |
1628805-46-8 |
| NIBR189 |
NIBR189 |
1599432-08-2 |
| SGC0946 |
SGC0946 |
1561178-17-3 |
| XEN445 |
(S)-2-(3-(PYRIDIN-2-YLMETHOXY)PYRROLIDIN-1-YL)-5-(TRIFLUOROMETHYL)BENZOIC ACID. HCL |
1515856-92-4 |
QQ
